Will OPEC+ begin to reverse large production cuts at its June 1 meeting? In large part, it will depend on whose oil market outlook is closest to the mark, writes Mark Finley, fellow in energy and global oil. He examines several forecasts and outlines the issues in a new commentary.
Mark Finley explains the cost-benefit analysis behind the Saudi government's recent move to pause plans to increase spare oil production capacity — and why spare capacity still equates to power in the oil market.
When the OPEC+ group met last week and agreed to extend production cuts through the first quarter of 2024, the market was unimpressed. Fellow in Energy and Global Oil, Mark Finley, outlines the meeting’s outcomes and discusses why the recent agreement “could augur a year of difficult meetings ahead” in a new commentary.
Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.
The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.